Coherus Oncology, Inc.
CHRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001512762
No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Members of Congress who traded CHRS
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 1
- Filings
- 1
- Members
- 1
- Buys / sells
- 0 / 1
- Estimated volume
- $32.5K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Shri ThanedarDemocrat · House · MI | 1 | 0 / 1 | $32.5K | Jan 23, 2023 | Feb 9, 2023 |
Trades
Every reported trade in Coherus Oncology, Inc., newest filings first.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.